StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Business model problem here

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon Mar 22, 2022 7:16pm

118 Views

Post# 34536130

RE:RE:Business model problem here

"The problem was recruiting healthcare groups and large employers." - No, the problem was Jimmy, was and still is trying to fake it until he makes it

"Our end-to-end program is amazing." - Must be true as nailbiter said so.

"It is proven" - bullshit, where is your proof, oh yeah in your mind. Smoke some more dope, do some shrooms, or publish another one of your anal/oral/poop oriented visuals. Quoting Tripp, what could go wrong.

Nailbiter1 wrote:

Directvoice wrote:
I realize that maybe the new business model that Stage now is promoting have a scale problem that the old model didn't have. The old model was to sale tests. It costs a lot to establish your test in the medicsl market at first but you could end up making money.

The new model is to use telehealth to reach customer but you are limited by the number of staf and oncologist that you have. Cheaper to start but limited...

What do you think?

The problem was recruiting healthcare groups and large employers.

"Okay, if we buy your tests and find out we have 10% of our workforce at high risk / up to their eyes in trouble, what's next?"

Tripp... "Hey you are on your own. Thanks for trusting us and good luck with all that . Have a nice day".

Instead we offer something more.

Our end-to-end program is amazing.

Our team of oncologists have a patented treatment protocol that will assist you and your big fancy oncologist, in that big fancy hospital, achieve maximum positive treatment if required.

It is proven and if you can get 64% better results from being on it, you would be a fool to refuse it.